Patents by Inventor Oncogenex Technologies Inc.

Oncogenex Technologies Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense Formulation
    Publication number: 20130131150
    Abstract: A room temperature stable and minimal aggregate liquid formulation comprises an oligonucleotide comprising Seq ID No. 1: or comprising a variant oligonucleotide in which no more than 3 non-sequential bases are different from Seq. ID NO. 1 and an aqueous carrier comprising a aggregation-preventing compound selected from the group consisting of mono and disaccharides and/or sugar alcohols.
    Type: Application
    Filed: January 24, 2013
    Publication date: May 23, 2013
    Applicant: ONCOGENEX TECHNOLOGIES INC.
    Inventor: Oncogenex Technologies Inc.